This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Abcertin

Isu Abxis Co., Ltd.

Drug Names(s): imiglucerase, ISU302

Description: Abcertin is a CHO cell derived, human macrophage-targeted recombinant human beta-glucocerebrosidase. Its structural, physicochemical, biological, and immunological properties are comparable to the reference product, Cerezyme.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug